Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,064 | 34,764 | 17,896 | 14,811 | 5,050 |
| Marketable Securities | 93,975 | 88,282 | 44,786 | 37,753 | 49,042 |
| Receivables | 1,613 | 1,640 | 2,232 | 2,444 | 2,209 |
| TOTAL | $112,657 | $125,904 | $66,725 | $55,737 | $57,264 |
| Non-Current Assets | |||||
| PPE Net | 4,058 | 3,975 | 3,767 | 3,533 | 3,999 |
| Other Non-Current Assets | 3,877 | 4,124 | 4,336 | 4,732 | 4,824 |
| TOTAL | $7,935 | $8,099 | $8,103 | $8,265 | $8,823 |
| Total Assets | $120,592 | $134,003 | $74,828 | $64,002 | $66,087 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,444 | 2,222 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,710 | 7,904 | 8,053 | 6,438 | 2,592 |
| Accrued Expenses | 5,210 | 4,924 | 2,791 | 5,985 | 3,972 |
| Other current liabilities | 1 | 1 | 1 | 1 | 199 |
| TOTAL | $18,422 | $16,843 | $11,889 | $13,422 | $8,412 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,206 | 16,133 | 18,079 | N/A | N/A |
| Other Non-Current Liabilities | 42,191 | 27,786 | 53,741 | 35,754 | 35,637 |
| TOTAL | $56,397 | $43,919 | $71,820 | $35,754 | $35,637 |
| Total Liabilities | $74,819 | $60,762 | $83,709 | $49,176 | $44,049 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,471 | 43,314 | 41,186 | 27,355 | 24,773 |
| Common Shares | 434 | 417 | 276 | 265 | 247 |
| Retained earnings | -803,965 | -773,696 | -781,102 | -749,524 | -732,933 |
| Other shareholders' equity | -84 | -134 | -184 | -66 | -99 |
| TOTAL | $45,773 | $73,241 | $-8,881 | $14,826 | $22,038 |
| Total Liabilities And Equity | $120,592 | $134,003 | $74,828 | $64,002 | $66,087 |